Concerning Findings About Cannabis Use

While recreational marijuana is legal in 11 states as of November 2019, more states gravitating toward legalizing the recreational use of the substance, and 33 states allowing medical marijuana, there’s apparently no stopping this trend. Cannabis, in the form of marijuana, hemp, and cannabidiol (CBD)  is being used for pain relief, to alleviate stress, cope with anxiety, and a number of other mental health disorders and addictions. Yet, there’s a dearth of clinical studies that have been conducted on the overall effects on a user’s health. Clearly, as Crain’s Detroit Business points out, more research on marijuana and marijuana-based products is warranted. Cannabis Medical Research Still Hampered by Schedule I Classification A survey of 157 accredited medical schools in America revealed low acceptance of the scientific study of cannabis and the endocannabinoid system (ECS), with only 13 percent of the schools teaching endocannabinoid science to medical students, no schools with a department or director of endocannabinoid science, and none teaching endocannabinoid science as an organized course of study. Furthermore, only 21 of the 157 medical schools surveyed mentioned ECS in any course. Although the ECS controls inflammation, pain, and glucose and fatty metabolism, and its effects include regulation of homeostasis, and prevention of aging and disease, scientific research of cannabis and the ECS is thwarted by the Schedule I classification of cannabis by the federal...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Medications Substance Abuse Cannabis Marijuana Source Type: blogs